AU2001289930A1 - Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis - Google Patents

Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis

Info

Publication number
AU2001289930A1
AU2001289930A1 AU2001289930A AU8993001A AU2001289930A1 AU 2001289930 A1 AU2001289930 A1 AU 2001289930A1 AU 2001289930 A AU2001289930 A AU 2001289930A AU 8993001 A AU8993001 A AU 8993001A AU 2001289930 A1 AU2001289930 A1 AU 2001289930A1
Authority
AU
Australia
Prior art keywords
antibodies
diagnosis
therapy
production
human antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289930A
Inventor
Ghislain Opdenakker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Original Assignee
Stichting Rega VZW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega VZW filed Critical Stichting Rega VZW
Publication of AU2001289930A1 publication Critical patent/AU2001289930A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2001289930A 2000-09-25 2001-09-25 Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis Abandoned AU2001289930A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00203325 2000-09-25
EP00203325 2000-09-25
PCT/EP2001/011140 WO2002026829A1 (en) 2000-09-25 2001-09-25 Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis

Publications (1)

Publication Number Publication Date
AU2001289930A1 true AU2001289930A1 (en) 2002-04-08

Family

ID=8172060

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289930A Abandoned AU2001289930A1 (en) 2000-09-25 2001-09-25 Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis

Country Status (2)

Country Link
AU (1) AU2001289930A1 (en)
WO (1) WO2002026829A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2262529A4 (en) * 2008-03-03 2013-05-08 Dyax Corp Metalloproteinase 9 binding proteins
EP4350345A2 (en) 2011-06-23 2024-04-10 Ablynx N.V. Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
EP3020728A1 (en) 2011-06-23 2016-05-18 Ablynx N.V. Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
HUE031828T2 (en) 2011-06-23 2017-08-28 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9091D0 (en) * 1991-01-18 1991-01-18 Novo Nordisk As PROCEDURE FOR MANUFACTURING ANTIBODIES
WO1996000084A1 (en) * 1994-06-24 1996-01-04 Torchilin Vladimir P Use of autoantibodies for tumor therapy and prophylaxis

Also Published As

Publication number Publication date
WO2002026829A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
EP1374935A4 (en) Medical syringe, and method of producing the same
AU2002226668A1 (en) Methods, systems and devices for in vivo electrochemical production of therapeutic agents
AU2002346783A1 (en) Composite nonwoven, its use and method of manufacture
AU2002233152A1 (en) Device and method for imaging, stimulation, measurement and therapy, in particular for the eye
EP1182451A4 (en) Biosensor and method of producing the same
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
AU2001246909A1 (en) Tube for medical care and method for preparing the same
AU1468601A (en) Sorbent, method of making the sorbent, and method of using the sorbent in fixed bed applications
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
HK1049167A1 (en) Spherical telithromycin clusters, method for the producing and use thereof in the preparation of pharmaceutical forms.
EP1617810A4 (en) Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2001248839A1 (en) Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
AU2002237253A1 (en) Biosensor and method of producing the same
AU2001277737A1 (en) Novel substance having physiological activity, process for producing the same, and use
AU2001231278A1 (en) Apparatus for the dialysis of blood, method for fabricating the same, and methodfor the dialysis of blood
EP1273657A4 (en) Novel protein, process for producing the same and use thereof
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
AU2002319080A1 (en) Method for the diagnosis and therapy of renal cell carcinoma
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
AU6431400A (en) Method of producing multi-layered bristle material, multi-layered bristle and its use
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
AU2795202A (en) Klainetin and derivatives thereof, method for their production and the use of the same
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same